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Purpose: The number of non-responders to treatment among patients with chronic pain
(CP) is high, although intensive multimodal treatment is broadly accessible. One reason is
the large variability in manifestations of CP. To facilitate the development of tailored
treatment approaches, phenotypes of CP must be identified. In this study, we aim to identify
subgroups in patients with CP based on several aspects of self-reported health.
Patients and Methods: A latent class analysis (LCA) was carried out in retrospective data
from 411 patients with CP of different origins. All patients experienced severe physical and
psychosocial consequences and were therefore undergoing multimodal inpatient pain treat-
ment. Self-reported measures of pain (visual analogue scales for pain intensity, frequency,
and impairment; Pain Perception Scale), emotional distress (Patient Health Questionnaire,
PHQ-9; Generalized Anxiety Disorder Scale, GAD-7) and physical health (Short Form
Health Survey; SF-8) were collected immediately after admission and before discharge.
Instruments assessed at admission were used as input to the LCA. Resulting classes were
compared in terms of patient characteristics and treatment outcome.
Results: A model with four latent classes demonstrated the best model fit and interpretability.
Classes 1 to 4 included patients with high (54.7%), extreme (17.0%), moderate (15.6%), and low
(12.7%) pain burden, respectively. Patients in class 4 showed high levels of emotional distress,
whereas emotional distress in the other classes corresponded to the levels of pain burden. While
pain as well as physical and mental health improved in class 1, only the levels of depression and
anxiety improved in patients in the other groups during multimodal treatment.
Conclusion: The specific needs of these subgroups should be taken into account when
developing individualized treatment programs. However, the retrospective design limits the
significance of the results and replication in prospective studies is desirable.
Keywords: chronic pain, phenotyping, patient-reported outcomes, latent class analysis,
multimodal treatment
Introduction
Chronic pain (CP) has growing medical, social, and economic impact worldwide.1–3
Approximately 20% of the European adult population is suffering from chronic pain of
moderate to extreme intensity, seriously affecting patients’ quality of life4 and leading
to severe consequences such as disability and opioid abuse.5,6 In addition, many
patients show comorbidities such as depression, anxiety, or enduring personality
changes due to CP which may complicate treatment.7–9 The processes underlying the
development, prognosis, and treatment of CP are of a complex nature. In many cases, it
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is not possible to distinguish between biological and psycho-
social mechanisms underlying the development and persis-
tence of chronic pain.10 Therefore, the biopsychosocial
model for understanding and treating CP is very common,
as it focuses equally on the physical and psychosocial aspects
of pain.11 Based on this model, patients are frequently treated
within a “multimodal” setting where experts from different
specialties work together to treat physical as well as psycho-
logical and social aspects of CP.12 Several studies have
shown that patients suffering from chronic pain respond
very differently to multimodal treatments.12 However, rela-
tively little is known about specific subgroups of chronic pain
patients and why they respond differently to treatments.13 If
one could identify and characterize subgroups among CP
patients that do or do not benefit from multimodal treatment,
or even deteriorate, this knowledge could be used to design
tailored multimodal treatments for specific groups of CP
patients.
Patients with similar pain syndromes respond very
differently to treatment. Clinical trials in different pain
syndromes such as post-herpetic neuralgia, fibromyalgia,
and osteoarthritis found that there is more variability in
treatment responses between individuals than between
pain syndromes.14–16 Different pain mechanisms may be
active to varying degrees in patients, and these mechan-
isms may partly depend on patient characteristics, leading
to interpatient variation in treatment effects.13 These find-
ings suggest that there may be different subgroups (“phe-
notypes”) among patients with pain syndromes, and, that
these phenotypes may be similar across different pain
syndromes.13
A growing body of literature supports the assumption
that specific subgroups exist in patients with pain syn-
dromes. Previous studies have found two to nine sub-
groups in chronic pain patients.17–29 Among the existing
literature, a series of studies based on the Swedish Quality
Registry for Pain Rehabilitation (SQRP) is of particular
importance due to the representativeness and scale of
samples used.17–19 These studies were based on a wide
range of patient-reported outcome (PRO) measures from
patients who were about to participate in 4–8-week out-
patient interdisciplinary multimodal pain rehabilitation
programs. Baseline PROs were used as input variables to
a principal component analysis which was followed by
a hierarchical cluster analysis. One study in more than
35,000 CP patients found two subgroups, one group with
higher average ratings of pain variables and psychosocial
variables and one group with lower average ratings of
these variables.18 Another study in almost 15,000 CP
patients undergoing interdisciplinary multimodal pain
rehabilitation programs identified three subgroups with
patients in best, intermediate and worst clinical situations
based on pain and psychosocial measures at baseline.
Whereas patients in the worst situation deteriorated
throughout treatment, patients in best and intermediate
situations demonstrated improvements in outcomes.17
The existing literature on pain phenotyping shows
some shortcomings that should be addressed. First, most
studies have focused on specific pain conditions such as
fibromyalgia,26,27 low back pain,21,28 osteoarthritis,29 neu-
ropathic pain,16 or pelvic pain;23 however, only a minority
of the studies aimed to identify subgroups in a broader
population of chronic pain,17–19,22,24,25 although theoreti-
cal considerations (i.e., biopsychosocial model) and the
resulting treatment recommendations (i.e., multimodal
treatment) implicitly expect chronic pain to be similar
across many syndromes and patients.11,30 Furthermore,
studies carried out in the same CP patient population are
not easily comparable due to the use of different subgroup-
ing methods and choice of input variables. In earlier stu-
dies, cluster analysis was most often used to identify
subgroups. Although latent class analysis (LCA) offers
some advantages in subgroup identification, this method
is not yet widely used. For example, latent class analysis
permits the modelling of an underlying “latent” structure.
This allows a detailed comparison of different models
based on goodness-of-fit statistics.31–33 Third, in studies
of the same pain syndromes, different types of variables
were used to establish subgroups.13 The most frequently
used variables for statistical subgrouping were PRO mea-
sures, findings from physical examination (i.e., pain
locations),34 and diagnostic or experimental results (e.g.,
pain sensitivity ratings).13,15 These types of variables
reflect very different aspects of individuals’ pain experi-
ence, which further complicates the comparability of find-
ings. Fourth, the Initiative on Methods, Measurement, and
Pain Assessment in Clinical Trials (IMMPACT) recently
recommended measures to be included in any pain pheno-
typing study. In addition to the inclusion of other pain
instruments, the need to include mental health measures
was emphasized.13 The close relation between chronic
pain and mental conditions such as depression or anxiety
is also in accordance with available empirical evidence
and widely recognized in the field.11,35 However, until
now, many studies that aimed to identify subgroups of
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pain patients did not include measures for depression and
anxiety as input variables.
Taken together, existing studies that aimed to identify
subgroups in heterogeneous CP samples did either not use
PROs as input measures,22 included only very specific
domains24 or did not use latent class analysis.17–19,22,24,25
Therefore, we try to address some of these aspects by
using latent class analysis to identify subgroups in
a sample of CP patients that is different from the samples
used in previous subgrouping studies. The sample includes
patients with CP of different origin and manifestation who
received multimodal inpatient treatment due to severe
physical and psychosocial consequences. We chose
a range of baseline PRO measures as input to the sub-
grouping analysis that reflects physical and psychological
aspects of pain including depression and anxiety. Our
specific aims are 1) to identify latent classes based on
baseline PRO measures of CP patients undergoing multi-
modal inpatient treatment, 2) to compare latent classes in
terms of demographic and clinical background character-
istics, and, 3) to evaluate differences in changes during
treatment between latent classes.
Methods
Setting, Sample, and Data Assessment
A retrospective analysis in clinical routine data was carried
out in patients with chronic pain undergoing multimodal
inpatient treatment at the Department for Psychosomatic
Medicine at Charité – Universitätsmedizin Berlin,
Germany. The data were assessed electronically on
the day after admission and on the day before discharge
between January 2011 and December 2014. In rare cases,
for example, if technical issues occurred, the assessments
were deferred to the following day. All datasets from
patients with age ≥18 who underwent multimodal treat-
ment for their chronic pain were included. To receive
multimodal treatment for their pain, in line with the guide-
lines by the German public insurance,36 patients had to
suffer from persistent pain (duration > 6 months) with
severe physical, psychological and/or social consequences
(with or without an underlying persistent somatic condi-
tion). Furthermore, they had to fulfill at least three of the
following five criteria: 1) the pain affects the quality of life
and/or the ability to work; 2) a previous unimodal treat-
ment (e.g., medication) or surgery was not successful; 3)
dependency on pain medication; 4) mental comorbidity; 5)
severe somatic comorbidity.36
During multimodal inpatient treatment, all patients
received regular medical visits, consultations with pain
specialists, psychological treatment (individual and group
setting), art therapy, music therapy, progressive muscle
relaxation, and exercise including physiotherapy and
aqua gym.30 Cases were excluded, if data were missing
on entire scales (e.g., due to the change of assessment
battery for organizational reasons) that had been chosen
for the statistical subgrouping.
The study was approved by the Charité’s Ethics
Committee. Due to the secondary analysis in routine
data, patient consent to review and obtain data from their
medical records was not required. The data were handled
in accordance with the General Data Protection Regulation
(GDPR) of the European Union. The study was carried out
in compliance with the Declaration of Helsinki.
Indicators for Statistical Subgrouping
Selection of Instruments
As PROmeasures reflect patients’ individual pain perception
and may, therefore, enlighten mechanisms determining inter-
individual differences in response to pain treatment,13 PRO
measures were used as the basis for phenotyping instead of
blood values, imaging results, or medication intake.13
However, due to the retrospective design of the current
study, the number of options was limited and we have tried
to find the best possible compromise between current
recommendations13 and existing data. We combined differ-
ent aspects of pain perception (intensity, frequency, impair-
ment, sensory and affective pain perception) with indicators
of emotional functioning (depression, anxiety) and physical
health as input measures for the LCA.
Input Instruments
(a) Pain intensity, frequency, and impairment (visual ana-
logue scales, VAS): The patients were asked to place
a cursor on a scale between “0” (= “no pain”/“no
impairment”/“never”), and “10” (= “intolerable
pain”/“great impairment”/“permanent pain”) accord-
ing to their currently perceived pain. The intensity
VAS has been shown to be a reliable and valid mea-
sures in many studies.37 Although there are no valida-
tion studies for frequency and impairment scales,
VAS has been adapted for many other patient-
reported symptoms and those have generally demon-
strated satisfactory validity (for example38).
(b) Pain Perception Scale (PPS): This instrument
assesses pain perception with 24 items. The content
Dovepress Obbarius et al
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of each item is rated from `Not true` (1) to `Entirely
true` (4). Two main scales allow the differentiation
between affective characterization (14 items, score
range 14 to 56; example item: “I feel my pain is
unbearable.”) and modes of sensory characteriza-
tion (10 items, score range 10 to 40; example item:
“I feel my pain as cutting.”) of pain. Higher scale
scores correspond to higher degrees of affective
and/or sensory characterization, respectively.
Psychometric properties including reliabilities for
the affective characterization (Cronbach’s α =
0.93) and sensory characterization (α = 0.85) sub-
scales as well as the test-retest-reliability (rr = 0.95)
were satisfactory.39
(c) Patient Health Questionnaire 9-item (PHQ-9): This
9-item instrument is used in many settings to screen
for the presence and severity of depressive symptoms.
Because each of the 9 items is scored from `Not at all`
(0) to `Nearly every day` (3), scale scores range from 0
to 27. Higher scores indicate higher severity of depres-
sion. A PHQ-9 score ≥10 has a sensitivity of 88% and
a specificity of 88% for major depression. The instru-
ment has shown sufficient reliability (α = 0.89 to 0.86
depending on the study) and test-retest-reliability (rr =
0.84).40
(d) Generalized Anxiety Disorder 7-item (GAD-7):
This 7-item instrument is broadly used to screen
for the presence and severity of anxiety. Because
each of the 7 items is scored from 0 “not at all” to 3
“nearly every day”, the GAD-7 scale score ranges
from 0 to 21. Higher scores indicate higher severity
of anxiety. A GAD-7 score of ≥10 has a sensitivity
of 89% and a specificity of 82% for a generalized
anxiety disorder. The instrument has shown suffi-
cient reliability (α = 0.92) and test-retest-reliability
(rr = 0.83).41
(e) Short Form Health Survey 8-item (SF-8): This instru-
ment is the brief version of the SF-36, designed to
assess general health related quality of life. For the
LCA, the physical component score (PCS) is used as
an indicator reflecting physical health. The PCS
includes 4 items (general health, bodily pain, role-
physical, and physical functioning). T-scores with
a general populationmean of 50 and standard deviation
of 10 are reported. Higher values indicate better health.
Psychometric properties including reliabilities for the
full instrument (α = 0.70 to 0.88 depending on the
study) and the PCS (α = 0.88) as well as the test-
retest-reliabilities for the full instrument (rr = 0.59 to
0.70 depending on the study) and the PCS (rr = 0.73)
were satisfactory.42
Additional Instruments and
Characteristics for Description of Latent
Classes
Perceived Available Support (PAS): This is one of the sub-
scales from the Berlin Social Support Scales (BSSS) which
allows the assessment of emotional (example item: “When I’m
sad, there are people who cheer me up.”) and instrumental
social support (example item: “There are people who offer
their help when I need it.”). Each item is scored from 1 “not
true” to 4 “totally true”. The scores for each 4-item subscale
range between 4 (low social support) and 16 (high social
support). The reliability was sufficient (α = 0.83).43
Patient characteristics: Patients’ partnership status,
level of education, work status, prior psychological treat-
ment, prior psychosomatic inpatient treatment, frequency
of intake of pain medication, and number of consultations
during the last 6 months were assessed at baseline.
Comorbidity and multimorbidity: Comorbid diagnoses
and multimorbidity (i.e., number of diagnoses including
pain disorder) were obtained from discharge letters (“clin-
ician-reported”). Note that the number of clinician-reported
diagnoses is a common measure of multimorbidity.44
Analysis Strategy
Data Preparation
All patient-reported data were obtained from the department’s
data repository. Overall, N=638 patients with CP were identi-
fied. Due to missing data on entire instruments at admission,
227 cases were excluded. The final dataset included N=411
patients. To evaluate whether the exclusion of caseswould bias
the LCA results, a sensitivity analysis was carried out. We
conducted T-Tests and Wilcoxon–Mann–Whitney tests (for
non-parametric data) to compare included and excluded
records in terms of demographic and clinical background
characteristics and baseline pain scores (all 638 patients com-
pleted pain intensity, frequency and impairment scales).
Statistical Subgrouping
To identify underlying latent classes in the sample of
patients with CP, a LCA was conducted.45 The number
of latent classes to be retained was determined based on
established criteria including statistical performance
measures and pragmatic evaluation.45–47 As there is no
single standard statistic to evaluate goodness of fit of
Obbarius et al Dovepress
submit your manuscript | www.dovepress.com
DovePress




























































Powered by TCPDF (www.tcpdf.org)
                               1 / 1
a latent class model, several fit indices were considered:
For absolute model fit the likelihood-ratio statistic (G2)
was calculated. With higher values the probability that
the null hypothesis (= no subgroups exist) can be
rejected increases. For comparison models that postulate
the existence of different number of latent classes, the
following indices expressing relative model fit were
used: The Akaike information criterion (AIC), the con-
sistent Akaike information criterion (cAIC), and the
Bayesian information criterion (BIC). The lower the
value of the information criterion, the better the model
fits. These indices take parsimony into account which is
a principal stating that, if models are compared, all else
being equal, simpler models (with fewer parameters) are
preferred to more complex models.45 The BIC tends to
select simpler models than the AIC, and in a Monte
Carlo simulation, it has been shown to be the most
reliable criterion when deciding on the optimal latent
class model47 which is why we primarily used the BIC
(supported by the other criteria) to determine the num-
ber of latent classes. In addition, the maximum log
likelihood and conditional bootstrap likelihood ratio
test (BLRT) were used to determine if the model fit
could be improved, if classes were added.48 Pragmatic
evaluation included the minimum average posterior
probability of cluster membership (>0.7), interpretability
(classes are clearly distinguishable), and parsimony
(each class has a sufficient sample size for further ana-
lysis; n≥50).31
Profiles for Each Class
After determining the optimal number of latent classes, in
order to profile the emergent latent classes, CP patients
were assigned to the latent class for which they had the
highest likelihood of belonging. Post hoc descriptive sta-
tistics were calculated to create profiles including demo-
graphic, medical and psychosocial aspects for each class.
To compare characteristics between classes, one-way ana-
lysis of variance (ANOVA) was used for interval and ratio
scales and Kruskal–Wallis test was used for nominal and
ordinal scales. Eta2 (η2) was used to illustrate effect sizes
for significant results. η2≥0.01, ≥0.06, ≥0.14 were
regarded as small, medium, and large effects, respec-
tively. To adjust for multiple comparisons in post hoc
analyses, Tukey–Kramer adjustment was used for interval
and ratio scales. To calculate post hoc differences for
ordinal scales, multiple Wilcoxon–Mann–Whitney tests
were conducted. In addition, to evaluate whether
trajectories of change throughout treatment are different
between classes, changes were compared for each input
instrument. Due to missing data at discharge, a repeated
measures analysis of variance (RM-ANOVA) in a linear
mixed model framework was used which allows to
account for missing data by maximum likelihood (ML)
estimation. In addition, changes of input instrument
scores within classes during treatment were captured by
subtracting Least-square (LS) means (as resulting from
RM-ANOVA) from admission and discharge scores.
Paired T-Tests were then performed to evaluate significant
differences. Tukey–Kramer adjustment was used to
account for multiple comparisons.
Statistical analyses were conducted with SAS® 9.4
(Cary, NC, USA) and R 3.4.2,49 R-packages poLCA50
and ggplot251 were used for LCA and figures, respectively.
Results
Sample Description and Sensitivity
Analyses
A sample of N=411 patients with CP was analyzed. The
mean age was 49.5 years, and 66.7% were female.
Twenty-four percent did have a university entrance
diploma and 7% did not have any educational qualifica-
tion. Approximately 50% were currently working, 20%
were seeking employment, and 24% were unable to
work. Patients showed high comorbidity, mean number
of diagnoses was 6.8. More than 50% had prior psycholo-
gical treatment and over 60% took pain medication at least
four times a week. Detailed sample characteristics are
provided in (Table 1). The comparison of excluded
(n=227) and included (n=411) cases for the LCA revealed
that excluded patients were approximately 4 years older
(Mexcluded=54, SDexcluded=14 years; Mincluded=50,
SDincluded=13 years; p<0.01), had longer inpatient stays
(Mexcluded=21, SDexcluded=13 days; Mincluded=17,
SDincluded=9 days; p<0.01), and showed slightly lower
pain impairment at baseline (Mexcluded=5.4, SDexcluded=3.4;
Mincluded=5.8, SDincluded=3.1; p<0.05). There were no sig-
nificant differences on other sociodemographic or clinical
variables.
Determining the Number of Latent
Classes
The fit statistics for the two to ten class models are pro-
vided in (Table 2). Absolute model goodness-of-fit statistic
G2 showed high values and the null-hypothesis of exact fit
Dovepress Obbarius et al
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was hence rejected for all tested models. The BIC and
cAIC suggested best model-fit for a model with four
classes. The BLRT indicated that models with up to 9
classes were tenable as each model with k classes showed
significant improvement in model fit compared to the less
complex model with k-1 classes. Pragmatic evaluation of
the four-class model demonstrated satisfactory values for
the average posterior probabilities of cluster membership
(C1: MC1=0.96, SDC1=0.09; MC2=0.92, SDC2=0.14; MC3
=0.92 SDC3=0.13; MC4=0.99, SDC4=0.04). In addition,
sample sizes of groups were sufficient as the smallest
class still contained 52 patients. Furthermore, in subse-
quent analyses, the four latent classes showed clear differ-
ences in terms of input measures and other variables used
for profiling (see below).
Differences in Pain Characteristics, and in
Emotional and Physical Health Across
Latent Classes
In (Figure 1), we graphically depict the average scale scores of
input measures across the four latent classes. Scales were
standardized to facilitate interpretation. A summary of prob-
abilities, labels and descriptions of latent classes is given in
(Table 3). Instrument scores and patient characteristics across
classes are presented in (Table 4).
Class 1 was the largest group (54.7%) patients in this
group had high to very high levels of pain intensity
(M=6.5, SD=1.8), impairment (M=6.8, SD=2.0), and fre-
quency (M=8.1, SD=2.2), medium affective pain percep-
tion (M=39.7, SD=7.7) and medium to low sensory pain
perception (M=21.4, SD=5.9). Levels of depression
(M=13.4, SD=4.8) and anxiety (M=9.2, SD=4.7) were
moderate, and these patients reported poor physical health
(M=28.7, SD=6.3). Thus, this class was labeled “High
pain burden and medium emotional distress”.
Patients in class 2 (17.0%) had the highest pain intensity
(M=7.8, SD=2.0), impairment (M=8.2, SD=2.3), and fre-
quency (M=8.9, SD=1.5). In addition, the patients in class 2
demonstrated high levels of affective pain perception (M=51.5,
SD=4.3), sensory pain perception (M=30.0, SD=7.5), levels of
depression (M=20.4, SD=4.2) and they had the lowest physical
health status (M=24.8, SD=4.5). Therefore, class 2 was
labelled “Extreme pain burden and emotional distress”.
Pain levels in class 3 (15.6%) were lower than in classes 1
and 2. While pain intensity (M=3.2, SD=1.6) and impairment
(M=4.2, SD=1.9) were relatively low, pain frequency (M=5.7,
SD=2.8) was notably larger. Thus, those patients seemed to
Table 1 Demographic and Clinical Background of Chronic Pain
Patients (N=411)
M SD
Age in years 49.5 13.4
Min Max
Age range in years 18 86
N %
Gender (female) 274 66.7
Living with partner 207 50.4
Educational level N %
University entrance diploma 100 24.3
Certificate of secondary education 189 46.0
Certificate of primary or lower secondary education 90 21.9
Without educational qualification 30 7.3
Work status N %
Student/apprentice 9 2.2
Retired/unable to work 96 23.5
Homemaker 66 16.1
Employed 147 35.9
Seeking employment 84 20.4
Other 7 1.7
Comorbiditya N %
Ischemic heart disease 18 4.4
Hypertension 127 30.9
Asthma, COPD, chronic bronchitis 34 8.3
Chronic renal failure 9 2.2
Chronic liver disease 52 12.7
Diabetes mellitus 31 7.5
Cerebrovascular disease 9 2.2








Somatoform disorder 32 7.8
Substance abuse 27 6.6
Opioid abuse 15 3.6
M SD
Multimorbidity (number of diagnoses) 6.8 3.5
Treatment history N %
Prior psychological treatment 219 53.5
Prior psychosomatic inpatient treatment 115 28.1
Intake of pain medication >3x/week 259 63.0
>10 Consultations of doctors within 6 months 145 35.3
M SD
Duration of inpatient stay (days) 17.0 9.2
Note: aThe diagnoses are not mutually exclusive.
Abbreviations: COPD, chronic obstructive pulmonary disease; M, mean; N,
count; SD, standard deviation; %, prevalence.
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experience pain of lower levels relatively frequent. Affective
pain perception (M=29.2, SD=9.5) and sensory pain percep-
tion (M=17.7, SD=6.6), and levels of depression (M=7.6,
SD=4.8) and anxiety (M=5.1, SD=4.2) were the lowest com-
pared to the other classes. Physical health (M=36.3, SD=8.7)
was better than in classes 1 and 2, and not different from class
4. Class 3 was labelled “Moderate pain burden and some
emotional distress”.
Patients in class 4 (12.7%) did report very low
levels of pain intensity (M=0.2, SD=0.4), impairment
(M=0.5, SD=1.2), and frequency (M=0.4, SD=1.0).
While the standardized scale scores of all input
instruments in the other classes were similar within
each class, pain scores in class 4 were markedly
lower than the other instrument scores (Figure 1). In
addition, the levels of pain perception, depression,
anxiety and physical health exceeded those in the
class with the next highest pain levels (class 3).
Patients in class 4 demonstrated high affective pain
perception (M=34.4, SD=11.9) and medium to low
sensory pain perception (M=19.1, SD=7.0). In addition,
levels of depression (M=11.2, SD=5.7) and anxiety
(M=7.2, SD=5.0) were moderate. Compared to class 1
and 2, physical health was higher (M=33.2, SD=10.6).
Table 2 Fit Statistics and Information Criteria for the 2 to 10-Class Model
Classes Parameters G2 df AIC cAIC BIC LL BLRT p-value
2 65 3730 346 8735 9505 8996 −4303 <0.001
3 98 3437 313 8508 9061 8902 −4156 <0.001
4 131 3217 280 8354 9000 8881 −4046 <0.001
5 164 3085 247 8287 9012 8946 −3980 <0.001
6 197 2990 214 8258 9110 9050 −3932 <0.001
7 230 2908 181 8243 9246 9167 −3892 0.016
8 263 2830 148 8231 9396 9288 −3852 0.020
9 296 2769 115 8236 9542 9425 −3822 0.041
10 329 2702 82 8235 9717 9557 −3789 0.059
Abbreviations: AIC, Akaike information criterion; BIC, Bayesian information criterion; BLRT, bootstrap likelihood ratio tests; cAIC, consistent Akaike information
























Class 1: "High pain burden" (54.7%)
Class 2: "Extreme pain burden" (17.0%)
Class 3: "Moderate pain burden" (15.6%)
Class 4: "Low pain burden" (12.7%)
Figure 1 Latent class-specific profiles of pain characteristics and emotional and physical functioning. The means of standardized indicator variables (Z-scores, mean = 0,
standard deviation = 1) in each latent class are depicted. Higher z-scores correspond to less favorable values (i.e., high pain, high depression, low physical health), whereas
lower z-scores correspond to more favorable values. Sizes of latent classes are provided in parentheses in the legend.
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Class 4 was labelled “Low pain burden and moderate
emotional distress”. (Figure 1, Tables 3 and 4)
Differences in Social Support,
Sociodemographic Background,
Comorbidities, and Clinical
Characteristics Across Latent Classes
Detailed differences are shown in Table 4 and findings are
summarized below:
Social Support
We did not find differences in emotional social support
between classes, but mean levels of instrumental social
support were significantly (p=0.014) different across latent
classes. In particular, patients in class 2 reported signifi-
cantly lower levels of instrumental social support than
patients in classes 1 and 3.
Sociodemographic Variables
Patients in class 4 were on average 10 to 15 years older
than patients in the other classes (p<0.001). Class 1 had
the highest proportion of patients living with a partner
(56.4%), which was significantly higher than in classes 2
and 3 (41.4% and 37.5%, respectively, p=0.016).
Comorbidity and Multimorbidity
The proportion of patients with a clinician-reported diagnosis
of depression was between 50% and 63% in classes 1.2, and
4, which was significantly higher than in class 3 (26%,
p<0.001). A diagnosis of headache was more prevalent in
classes 1 and 2 (17% and 19%, respectively) than in classes
3 and 4 (5% and 6%, respectively; p=0.015). Prevalences of
comorbidities that are usually associated with higher age, such
as ischemic heart disease, chronic liver disease, or diabetes
mellitus52 were higher in class 4 (class with highest age).
Treatment History
Regarding patients’ treatment history, latent classes dif-
fered most in terms of pain medication intake. Much
more patients in class 2 (81%; p=0.009) took pain medica-
tion more than three times a week than in class 3 (44%)
and class 4 (52%). Furthermore, the proportion of patients
who had received prior psychological treatment was sig-
nificantly (p=0.029) higher in class 1 (57%) and class 2
(60%) than in class 3 (39%). Accordingly, significantly
more patients in class 2 (51%, p=0.013) were frequently
(>10 times) consulted by medical doctors within the 6
months prior to admission than patients in the other three
latent classes (17–31%). Mean duration of inpatient stay
ranged from 15 days (class 3) to 19 days (class 4), but
these differences did not reach statistical significance.
Changes in Pain Burden and in Emotional
and Physical Health During Treatment and
Differences in Change Scores Between
Latent Classes
Data for 25% to 51% of the patients (relative to the data at
admission in each class) were available at discharge
depending on the class and outcome instrument. While,
for example, pain intensity ratings in class 3 were only
available in n=16 (25%) patients, PHQ-9 ratings in class 2
were available in n=36 (51%) patients. The total sample
showed significant improvements on all outcome variables
apart from pain frequency during treatment (p≤0.025).
While mean changes in pain intensity (Δ=−0.54,






LC1 54.7 High pain burden and
medium emotional distress
Poor physical health, 10–15% more people living with partner than in other classes,
more headache than LC3 and 4; improvement in pain, depression, and physical health
throughout treatment (“treatment responder”)
LC2 17.0 Extreme pain burden and
emotional distress
Poor physical health, more headache than LC 3 and 4; less instrumental social
support; improvement in depression/anxiety, but no improvement in pain
LC3 15.6 Moderate pain burden and
some emotional distress
Good physical health, less depression diagnoses (~25% vs ~50% in other classes), no
change in pain ratings, anxiety or physical health, but improvement in depression
LC4 12.7 Low pain burden and
moderate emotional distress
Moderate physical health, 10–15 years older than other classes, more comorbidity;
increase in pain, predominantly in pain frequency, improvement in depression
Abbreviation: LC, latent class.
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p=0.025), impairment (Δ=−0.74, p=0.002) and frequency
(Δ=−0.11, p=0.665) were very small, changes in physical
health (Δ+2.25, p<0.001), depression (Δ=−4.26, p<0.001),
and anxiety (Δ=−2.66, p<0.001) were more substantial.
The RM-ANOVA which tested for differences in mean
change scores between latent classes for each outcome,
showed statistically significant results for pain intensity
(F3,130=11.12, p<0.001), pain impairment (F3,130=4.83,
p=0.003), and pain frequency (F3,130=15.23, p<0.001). The
results of the post hoc tests that tested the significance of
treatment effects for each latent class separately can be found
in (Table 5). Pain intensity levels significantly improved in
class one (Δ=−1.07, p=0.001) during treatment, while
patients in class 4 reported significantly higher levels of
pain intensity after treatment than at baseline (Δ=+1.75,
p=0.008). Accordingly, levels of pain impairment in class 1
were also lower following treatment than at baseline (Δ=
−4.41, p=0.008), and patients in class 4 reported pain sig-
nificantly more often following treatment than at baseline
(Δ=−4.41, p=0.008).
Change scores for physical health (F3,167=0.95,
p=0.416), depression (F3,173=1.33, p=0.267), or anxiety
(F3,172=0.51, p=0.673) were not significantly different
across classes. Patients in all four classes had significantly
Table 5 Patient-Reported Outcomes (PRO) During Treatment Across Latent Classes
PRO Admission Discharge Changea
Pain intensity LS-meanb SE LS-mean SE ΔLS-mean SE t pc
LC1 6.48 0.12 5.42 0.23 −1.07 0.25 4.25 0.001
LC2 7.83 0.22 6.68 0.38 −1.15 0.42 2.72 0.126
LC3 3.28 0.23 3.38 0.46 +0.10 0.50 −0.20 1.000
LC4 0.22 0.25 1.97 0.42 +1.75 0.48 −3.67 0.008
Pain Impairment
LC1 6.84 0.14 5.64 0.25 −1.21 0.27 4.41 0.001
LC2 8.21 0.24 6.95 0.41 −1.26 0.46 2.74 0.119
LC3 4.27 0.25 3.37 0.50 −0.90 0.54 1.66 0.713
LC4 0.47 0.28 1.35 0.46 +0.88 0.52 −1.69 0.691
Pain Frequency
LC1 8.03 0.16 7.16 0.27 −0.87 0.29 3.04 0.056
LC2 8.94 0.28 7.73 0.46 −1.21 0.48 2.53 0.191
LC3 5.63 0.29 5.43 0.55 −0.20 0.57 0.34 1.000
LC4 0.42 0.32 3.30 0.51 +2.89 0.54 −5.35 <0.001
Physical Health (SF-8)
LC1 28.58 0.49 31.28 0.72 +2.70 0.71 −3.77 0.005
LC2 24.79 0.89 26.39 1.24 +1.60 1.23 −1.30 0.898
LC3 36.14 0.93 36.62 1.46 +0.48 1.45 −0.33 1.000
LC4 33.18 1.01 34.03 1.47 +0.86 1.47 −0.58 0.999
Depression (PHQ-9)
LC1 13.45 0.33 9.48 0.47 −3.96 0.47 8.41 <0.001
LC2 20.36 0.59 15.00 0.79 −5.36 0.79 6.78 <0.001
LC3 7.71 0.61 4.71 0.97 −3.00 0.97 3.10 0.046
LC4 11.17 0.67 7.22 0.98 −3.95 0.98 4.04 0.002
Anxiety (GAD-7)
LC1 9.26 0.31 7.02 0.43 −2.24 0.40 5.55 <0.001
LC2 15.62 0.55 12.65 0.73 −2.97 0.68 4.34 0.001
LC3 5.25 0.58 2.98 0.87 −2.27 0.83 2.72 0.123
LC4 7.17 0.63 5.45 0.88 −1.71 0.84 2.05 0.454
Notes: aDifferences in estimated marginal means from the repeated measures analysis of variance (RM-ANOVA) in a linear mixed model framework, bestimated marginal
means, cTukey–Kramer adjustment was used to account for multiple comparisons, significant changes are bold.
Abbreviations: GAD-7, Generalized Anxiety Disorder 7 item version; LC, latent class; PHQ-9, Patient Health Questionnaire 9 item version; SF-8, 8-item version of the
Short Form (36) Health Survey, the physical component score (PCS) is used to reflect physical function.
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lower levels of depression (Δ =−3.00 to −5.36, p≤0.05)
following treatment, but only patients in classes 1 and 2
had also significantly lower (Δ =−2.24 to −2.97, p≤0.05)
levels of anxiety following treatment. Regarding physical
health, only patients in class one significantly improved (Δ
=+2.70, p=0.005) during treatment (Table 5).
Discussion
In this exploratory, retrospective study, we identified four
phenotypes in baseline data from patients suffering from
chronic pain who were about to receive multimodal inpa-
tient treatment. We observed several differences in PROs,
demographic characteristics, treatment variables and
comorbidities. In those patients, it appeared that latent
classes were able to predict change in pain intensity, pain
impairment, and anxiety throughout treatment. While
depression improved in all classes during multimodal
treatment, substantial improvements on the other outcomes
were only found in class 1. Pain intensity and impairment
even deteriorated during treatment in class 4. However,
due to the lack of data at discharge in more than half of the
patients, conclusions from the different courses of the
classes must be drawn with caution.
The largest group (class 1) presented high scores of
pain and depression as well as poor physical health at
admission and showed improvements in pain as well as
emotional and physical health during treatment. Therefore,
patients in this group – as compared to other groups – can
be characterized as treatment responders, although the
mean pain intensity level at discharge was still above 5/
10 on the VAS and clinicians usually aim to achieve a pain
level of 3/10 or below in CP patients.53 The other groups
were notably smaller (approximately 15%) and initial
levels of pain and depression varied significantly across
groups. All these groups (classes 2–4) showed an improve-
ment in emotional functioning (depression and/or anxiety)
while levels of pain remained unchanged or increased.
Class 2 was the group with extreme symptom burden
including highest pain and depression as well as lowest
physical health. In addition, the patients in this group took
the most painkillers and had the most contacts with doc-
tors within the last 6 months. Instrumental social support
was lower compared to other groups. These patients bene-
fited from the multimodal treatment in terms of their
depression, but not in terms of their pain level. One
would expect that both, the extent of pain and depression
would decrease during treatment. However, duration of
inpatient treatment was usually limited to 3–4 weeks due
to regulations of the reimbursement system in Germany.
Treatment might have been too short for patients in class 2
to show improvement in pain scores. In addition, as fol-
low-up data were not available for later points in time, it
remains unclear whether the treatment effect in terms of
pain might be delayed. Therefore, follow-up data collected
a few months after discharge or after extended inpatient
treatment programs would be of interest and should be
assessed in future studies. These heavily burdened class
2 patients could probably also benefit from more extensive
support in building a better social network, as this group
has the lowest level of social support. There is growing
evidence that social exclusion and pain are closely
linked,54 and consideration of social aspects in treatment
may, therefore, have an positive impact on pain levels.
Analogous to class 2, the patients in class 3 showed only
improvements in their depression, but not in their pain.
However, baseline levels of pain, emotional functioning,
and physical health in class 3 were – although clearly
below the mean values in the general population
(M=50) – still better than in the other groups.
Surprisingly, patients in class 4 reported low levels of
pain at admission but showed an increase during treat-
ment. Moreover, this finding is somewhat contradictory
to the higher values of pain perception. Although levels
of depression improved during treatment in these patients,
they reported increased levels of pain at discharge. It is
also remarkable that this group included on average sig-
nificantly older patients (by 10–15 years).
There are various explanations for the low pain ratings
at admission and for the deterioration during inpatient treat-
ment. Low pain experience could be explained by psycho-
logical phenomena, such as reduced pain due to a positive
treatment expectation55 or due to the removal of stressors
from everyday life (i.e., conflicts at work or in the family,
etc.). Another explanation is that these patients dissimulated
their pain, i.e. their actual pain levels were higher than
reported. Although malingering is more common in CP
patients, dissimulation has also been reported.56 However,
if patients were indeed dissimulating, this could have impli-
cations for their treatment. For example, these patients may
have been undertreated with pain medication which could
lead to more limitations due to pain.
Therapeutic effects in the group (e.g., equalization of pain
levels), therapeutic effects on self-perception (patients per-
ceive their pain more realistically during treatment), or sta-
tistical effects (regression to the mean) could, individually or
in combination, be responsible for the worsening of the pain
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during treatment.12,57 A practical implication for these
patients could be that practitioners should be careful when
interpreting very low pain levels in CP patients at admission.
Pain levels should, for example, be assessed repeatedly.
Our findings are partly in line with other studies that
aimed to identify subgroups in a sample of patients with CP
of different origins.17–19,24,25 Based on large samples from
the Swedish Quality Registry for Pain Rehabilitation (SQRP)
a series of three studies that used slightly different input
instruments identified two,18 three,17 and four19 subgroups
of CP patients. Like our study, the different groups in the
studies are characterized by different levels of pain burden.
Two studies17,18 included follow-up data after a multimodal/
multidisciplinary rehabilitation program which showed –
similar to our study – different trajectories of outcomes. For
example, patients in cluster 3 from Ringqvist et al17 had low
baseline scores and deteriorated during treatment. One of the
three Swedish studies can best be compared with our study,
as four subgroups were also found there: Bäckryd et al19
found four subgroups with different levels of pain, which
related to similar levels of psychological distress.
Remarkably, in contrast to our study, social distress was
found to be highest in a group that did not show the highest
pain burden but included more females and reported the
longest duration of pain.19 In addition to those large studies
in heterogeneous pain samples, there are a few subgrouping
studies in patients with back pain available.21,28 Due to the
wide range of manifestations in back pain patients, those
studies seem to be at least partly comparable with our
study.58 For example, one study investigated subgroups in
patients with low back pain.21 The best LCA solution showed
seven patient subgroups with a range of differences.
Consistent with our results, the degree of pain severity,
physical limitation and emotional suffering were similar
within the different subgroups. However, comparison of
existing studies remains challenging as different methods
and input instruments have been used so far. Future studies
should therefore always include those input variables listed
in the IMMPACT recommendations.13
Strengths and Limitations
The study was carried out in a heterogeneous clinical chronic
pain sample with a state-of-the-art statistical approach and
resulted in four clinically meaningful phenotypes which
may require different treatment approaches. As with all retro-
spective studies, some limitations must be considered. First,
the relatively large proportion of missing data might have
biased the results. The large variation in treatment responses
was due to 1) organizational reasons (i.e., some patients did
not complete the questionnaires and as pain scales were at the
end of the questionnaire, less data were available for these
variables than for variables that were assessed at the start of the
questionnaire), and due to 2) variation between classes (i.e.,
there was fewer VAS data available from patients in class 3
compared to the other classes). However, ML estimation was
used to account for missing data at discharge.
Second, the use of routine clinical data is the reason
why not all recommendations issued by IMMPACT13
could have been followed. In future studies, for example,
additional instruments recommended should be used to
assess further variables such as pain quality and sleep.
Another limitation was the fact that information
regarding the location of pain and the duration of pain
episodes could not be included.
Furthermore, differential treatment effects across latent
classes cannot be generalized, because – in contrast to
a (randomized) clinical trial – this variable as such has
not been manipulated.
In addition, it should be emphasized that multimodal
treatment in other settings may have been different from
what was given at Charité.
Finally, like other recent studies,17–19 the sample
included patients with different pain manifestations such
as back pain, neck pain, fibromyalgia, etc., and those
patients might have been treated separately in other set-
tings. As described above, our approach is based on the
idea that pain phenotypes are similar across different pain
conditions.13 However, this assumption must be supported
by further evidence in future studies.
Future Research
Future phenotyping studies in patients with chronic pain
should favor a prospective design. In addition, the application
of a two-step LCA (i.e., using categorical variables resulting
from a first LCA as input to a second LCA) as suggested by
another study21 as well as the inclusion of confounders45 (i.e.,
demographic variables) in the LCA would be promising
extensions. In addition, the identification of subgroups in
heterogeneous CP samples may help to provide further scien-
tific evidence for the new ICD-11 classification for chronic
pain,59 wherein CP of different origins, different pathophysio-
logical emergences, and with different clinical manifestations
have been classified in one chapter. Furthermore, the inclusion
of ecological momentary assessment data (real-time assess-
ments, several times daily) would allow to base the
Dovepress Obbarius et al






























































Powered by TCPDF (www.tcpdf.org)
                               1 / 1
subgrouping analyses on a broader range of pain experiences
that do even closer reflect patients’ reality.60
Conclusion
Four subgroups with differences in pain perception and emo-
tional distress were found in a sample of CP patients with
severe physical or psychosocial consequences. These results
could be a first step towards the development of more indivi-
dualized treatments for patients suffering from chronic pain.
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